Gynae BT 2017

Subgroup analysis (distant control) • 394 consecutive patients from 7 centres treated with RCHT and IGBT (5 centers enrolled selected patients) • Two groups based on univariate analysis

Low risk: 1B, 2A, 2B, 3A &N0, 1BN+ High risk: 2A-2B & N+, any 3B-4A